Short Description MeiraGTx develops aav gene therapy for ophthalmology solutions to advance healthy longevity.
Description MeiraGTx is a biotechnology organization focused on aav gene therapy for ophthalmology within the broader longevity and healthy aging landscape. It leverages advancements in gene therapy to create interventions aimed at extending healthspan and addressing age‑related conditions.